Mayo Clinic Experimental Dual-Drug Nanotherapy Crosses the Blood–Brain Barrier and Improved Survival in Preclinical Glioblastoma Models | Newswise
[ad_1] Newswise — JACKSONVILLE, Fla. — Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to a study published in Nature Communications Medicine. The strategy extended survival in preclinical models of glioblastoma, the most aggressive form of brain cancer. The nanotechnology-based approach packages two existing cancer drugs […]